Real-World Outcomes of Palbociclib with Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer: A Retrospective Study from Saudi Arabia.

Cancers (Basel) · 2026 · PMC13115174 · PMID 42073594

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significancep > 0.05actually significant

Other variables, including BMI, cancer type, endocrine therapy, family history of cancer, BRCA mutation status, and line of therapy ( Table 5 ), did not reach statistical significance ( p > 0.05), although trends were observed.

also in 111,027 other papers

showed a trendno p-value reported

For instance, patients on an SERD (fulvestrant) showed a higher hazard ratio (HR = 2.302, p = 0.0678), and those with non-visceral metastases (HR = 2.008, p = 0.0696) also showed a trend toward poorer outcomes without statistical significance. 3.4.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.